Literature DB >> 16832008

The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.

Homayoon Khanlou, Susan Sanchez, Michele Babaie, Catherine Chien, Gerald Hamwi, Juan-Carlos Ricaurte, Tomiko Stein, Laveeza Bhatti, Paul Denouden, Charles Farthing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16832008     DOI： 10.1001/archinte.166.13.1417

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  9 in total

1.  Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.

Authors:  Shikha Garg; Prasert Thongcharoen; Prabda Praphasiri; Anupong Chitwarakorn; Pornchai Sathirapanya; Stefan Fernandez; Kamonthip Rungrojcharoenkit; Wannee Chonwattana; Philip A Mock; Wichuda Sukwicha; Jacqueline M Katz; Marc-Alain Widdowson; Marcel E Curlin; Robert V Gibbons; Timothy H Holtz; Fatimah S Dawood; Sonja J Olsen
Journal:  Clin Infect Dis       Date:  2015-10-20       Impact factor: 9.079

2.  Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Aswani Vunnava; Dae-Goon Yoo; Jae-Min Song; Mark R Prausnitz; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

3.  Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.

Authors:  Jae-Min Song; Yeu-Chun Kim; Peter G Barlow; M Jaber Hossain; Kyoung-Mi Park; Ruben O Donis; Mark R Prausnitz; Richard W Compans; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2010-09-21       Impact factor: 5.970

4.  A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.

Authors:  Shital M Patel; Robert L Atmar; Hana M El Sahly; Thomas R Cate; Wendy A Keitel
Journal:  Vaccine       Date:  2009-11-18       Impact factor: 3.641

5.  Transcutaneous vaccination via laser microporation.

Authors:  Richard Weiss; Michael Hessenberger; Sophie Kitzmüller; Doris Bach; Esther E Weinberger; Wolf D Krautgartner; Cornelia Hauser-Kronberger; Bernard Malissen; Christof Boehler; Yogeshvar N Kalia; Josef Thalhamer; Sandra Scheiblhofer
Journal:  J Control Release       Date:  2012-06-29       Impact factor: 9.776

6.  Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials.

Authors:  Claudia Pileggi; Francesca Lotito; Aida Bianco; Carmelo G A Nobile; Maria Pavia
Journal:  BMC Infect Dis       Date:  2015-10-14       Impact factor: 3.090

7.  Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Dae-Goon Yoo; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

Review 8.  Host responses from innate to adaptive immunity after vaccination: molecular and cellular events.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  Mol Cells       Date:  2009-02-05       Impact factor: 5.034

Review 9.  Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis.

Authors:  Jenny L Schnyder; Cornelis A De Pijper; Hannah M Garcia Garrido; Joost G Daams; Abraham Goorhuis; Cornelis Stijnis; Frieder Schaumburg; Martin P Grobusch
Journal:  Travel Med Infect Dis       Date:  2020-09-06       Impact factor: 6.211
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.